HENRY CHRISTIAN O — SEC insider filings
SEC reporting owner CIK 1263805. 58 insider filings on record with FilingPulse; latest filed 2026-10-07.
Transaction summary — filings shown
Covers the 50 most recent of 58 filings on record, filed 2022-02-22 to 2026-10-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 42 legs across 36 filings — 1,527,843 shares, $26,919,392 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 37.
- Largest priced transaction: sale of 4,499 shares @ $4,499.00 ($20,241,001) in Ginkgo Bioworks Holdings, Inc., filed 2023-10-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Ginkgo Bioworks Holdings, Inc. (DNA) | Director | 23 | — | 18 legs · 171,985 sh · $20,787,084 | 13 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | See Remarks | 20 | — | 18 legs · 1,242,243 sh · $4,575,217 | 8 |
| Wave Life Sciences, Inc. (WVE) | Director | 7 | — | 6 legs · 113,615 sh · $1,557,091 | 16 |
Insider filings — HENRY CHRISTIAN O
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-07 | 4 | Wave Life Sciences, Inc. (WVE) | Grant/award (A): 10,700 @ $0 · Grant/award (A): 64,000 (derivative) @ $0 | EDGAR |
| 2026-09-16 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Sale (S): 5,000 @ $7.08 | EDGAR |
| 2026-06-15 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Grant/award (A): 25,000 (derivative) | EDGAR |
| 2026-03-04 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Sale (S): 12,497 @ $1.51 | EDGAR |
| 2026-03-03 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Grant/award (A): 920,810 @ $0 · Grant/award (A): 1,841,621 (derivative) @ $0 | EDGAR |
| 2026-02-19 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Sale (S): 331,793 @ $1.58 · Sale (S): 140,874 @ $1.63 | EDGAR |
| 2025-12-10 | 4 | Wave Life Sciences Ltd. (WVE) | Sale (S): 6,445 @ $12.75 · Option exercise (M): 42,000 @ $5.97 · Sale (S): 42,000 @ $12.75 · Option exercise (M): 15,000 @ $3.50 · Sale (S): 15,000 @ $14.07 · Option exercise (M): 30,000 @ $4.58 · +4 more | EDGAR |
| 2025-09-10 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Sale (S): 10,000 @ $10.92 · Sale (S): 10,000 @ $11.06 | EDGAR |
| 2025-08-13 | 4 | Wave Life Sciences Ltd. (WVE) | Grant/award (A): 12,700 @ $0 · Sale (S): 9,670 @ $8.81 · Grant/award (A): 76,200 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Option exercise (M): 10,822 · Option exercise (M): 10,822 (derivative) · Grant/award (A): 34,375 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | Wave Life Sciences Ltd. (WVE) | Option exercise (M): 10,500 @ $9.13 · Sale (S): 10,500 @ $9.77 · Option exercise (M): 10,500 (derivative) @ $0 | EDGAR |
| 2025-03-21 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Grant/award (A): 920,810 @ $0 · Grant/award (A): 1,841,621 (derivative) @ $0 | EDGAR |
| 2025-03-05 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Sale (S): 12,497 @ $1.41 | EDGAR |
| 2025-02-19 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Sale (S): 259,909 @ $1.88 | EDGAR |
| 2024-09-17 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Sale (S): 98,907 @ $1.75 | EDGAR |
| 2024-08-14 | 4 | Wave Life Sciences Ltd. (WVE) | Grant/award (A): 16,115 @ $0 · Grant/award (A): 32,230 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Option exercise (M): 105,263 · Option exercise (M): 105,263 (derivative) · Grant/award (A): 432,900 (derivative) @ $0 · Grant/award (A): 571,428 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Sale (S): 14,177 @ $4.87 | EDGAR |
| 2024-02-26 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Grant/award (A): 1,605,769 @ $0 | EDGAR |
| 2024-02-21 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Sale (S): 79,038 @ $5.96 · Sale (S): 1,979 @ $5.26 | EDGAR |
| 2023-12-15 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Sale (S): 20,000 @ $10 | EDGAR |
| 2023-11-06 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Sale (S): 4,500 @ $1.39 | EDGAR |
| 2023-10-06 | 4/A | Ginkgo Bioworks Holdings, Inc. (DNA) | Sale (S): 4,499 @ $1.78 | EDGAR |
| 2023-10-04 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Sale (S): 4,499 @ $4,499 | EDGAR |
| 2023-09-19 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Sale (S): 96,844 @ $10.12 | EDGAR |
| 2023-09-12 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Sale (S): 10,000 @ $10.45 | EDGAR |
| 2023-09-06 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Sale (S): 4,499 @ $2.23 | EDGAR |
| 2023-08-18 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Sale (S): 10,000 @ $10.50 | EDGAR |
| 2023-08-09 | 4 | Wave Life Sciences Ltd. (WVE) | Grant/award (A): 45,000 (derivative) @ $0 | EDGAR |
| 2023-08-04 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Sale (S): 4,499 @ $2.25 | EDGAR |
| 2023-07-06 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Sale (S): 4,499 @ $1.89 | EDGAR |
| 2023-06-21 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Grant/award (A): 105,263 (derivative) @ $0 · Grant/award (A): 139,860 (derivative) @ $0 | EDGAR |
| 2023-06-14 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Sale (S): 39,007 @ $1.84 | EDGAR |
| 2023-06-06 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Sale (S): 4,499 @ $1.63 | EDGAR |
| 2023-05-04 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Sale (S): 4,499 @ $1.16 | EDGAR |
| 2023-04-05 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Sale (S): 4,499 @ $1.32 | EDGAR |
| 2023-03-16 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Sale (S): 4,499 @ $1.37 | EDGAR |
| 2023-03-06 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Grant/award (A): 594,687 @ $0 · Sale (S): 13,769 @ $9.49 | EDGAR |
| 2023-02-22 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Sale (S): 1,530 @ $10.27 | EDGAR |
| 2023-02-03 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Sale (S): 4,499 @ $2.10 | EDGAR |
| 2023-01-06 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Sale (S): 4,499 @ $1.57 | EDGAR |
| 2022-12-05 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Sale (S): 4,499 @ $1.85 | EDGAR |
| 2022-12-02 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Sale (S): 45,000 @ $10.84 | EDGAR |
| 2022-11-07 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Sale (S): 49,490 @ $2.56 | EDGAR |
| 2022-09-19 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Sale (S): 91,307 @ $5.78 | EDGAR |
| 2022-08-17 | 4 | Wave Life Sciences Ltd. (WVE) | Grant/award (A): 21,000 (derivative) @ $0 | EDGAR |
| 2022-06-13 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Grant/award (A): 70,921 @ $0 · Grant/award (A): 108,516 (derivative) @ $0 | EDGAR |
| 2022-03-14 | 4 | Ginkgo Bioworks Holdings, Inc. (DNA) | Grant/award (A): 1,071,395 @ $0 | EDGAR |
| 2022-03-04 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Grant/award (A): 107,500 @ $0 · Grant/award (A): 642,300 (derivative) @ $0 | EDGAR |
| 2022-02-22 | 4 | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | Sale (S): 2,122 @ $11.09 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1263805 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs